Published Date: 15-02-2017
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, Europe Continuous Glucose Monitoring Systems (CGMS) Market, the Europe Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 28.7% during 2016 -2022.
The Sensors market dominated the Europe Continuous Glucose Monitoring Systems Market in 2015, and wouldgrow at a CAGR of 30% during the forecast period. The Transmitters & Receivers market is expected attain a market size of $175.8 million by 2022.
The ICUs market followed the Diagnostic centers/clinics market in the Europe Continuous Glucose Monitoring Systems Market in 2015, and is expected to grow at a CAGR of 28.7% during the forecast period.
The report highlights the adoption of Continuous Glucose Monitoring Systems in Europe.Based on the Component, the Europe Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe region.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
The market is segmented based on Component, End User and Country.